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In wild·type Azorhizobium cauUnodans ORSS71, nicotinate served both as anabolic substrate for NAD+ 
production and as catabolic substrate for use as the N source. Catabolic enzyme activities were great~ from 
cultures grown with nicotinate as the N source and least when cultures were grown with ammonium as the N 
source. Vector insertion mutants unable to catabolize nicotinate (nic::Vi mutants) still required micromolar 
quantities of this compound for growth. Therefore, A. caulinodans wild type is NAD+ auxotrophic. As the first 
two interniediates in A. cauUnodans nicotinate catabolism, two cyclic compounds, 6-hydroxynicotinate and 
1,4,S,6.tetrahydro-6-oxonicotinate, were identified. These compounds were purified from the growth medium 
of strain 61009 (a nic::Vi mutant) by high-performance liquid chromatography; their identities were 
subsequeQtly confirmed by UV absorbance, nuclear magnetic resonance, and mass spectra. The conversion of 
1801 mol of nicotinate to 6·hydroxYnlcotinate consumed O.S mol of Oz. From isotopic incorporation 
experiments, water was the hydroxyl-equivalent source. A nicotinate hydroxylase activity proved to be·ceU 
waU,membrane associated; this activity served as direct electron dono... (not indirect via NADP+) to Oz via 
membrane electron transport. These catabolic reactions have not previously been witnessed together in the 
same organism. A. caulinodans nicotinate catabolism seems coupled to Nz fixation, although the explicit 
mechanism of this coupling remains to be determined. . 
Not only does Azorhizobium caulinodans ORS571 require Pseudomonas putida (formerly Pseudomonas ovalis) nico­
nicotinate supplementation for growth in a defined minimal tinate hydroxylases are membrane-bound complexes, in­
medium, it also uses nicotinate as the sole N source (6, 7). cluding cytochromes, that catalyze electron transport to O2 
As both a symbiotic and asymbiotic N2-fixing strain, A. (13-15). 
caulinodans is the only characterized member of the Rhizo­ P. putida has a nicotinate-driven respiratory chain that 
biaceae clearly able to use N2 as the N source for its own terminates at a cytochrome oxidase not reduced by electrons 
growth (6). However, because it must be supplemented with from NADH or succinate (15). In addition, nicotinate hy­
nicotinate, which is catabolized under N2-fixing conditions, droxylase and N,N,N' ,N'-tetramethyl-p-phenylenediamine 
A. caulinodans is not a diazotroph. Rather, it conducts (TMPD) both seem to reduce the same cytochrome c and 
synergistic N2 fixation and nicotinate catabolism (16), as cytochrome oxidase. This nicotinate-TMPD electron trans­
evidenced by the following experiments. When N2~fixing A. port chain has been seen in both P. putida and P.fluorescens 
caulinodans cultures under an atmosphere of97% N2-3% O2 (13, 15). In fact, the physiological role of TMPD oxidase 
are supplemented with IG-fold-augmented nicotinate levels activity in P. putida is thought to be the hydroxylation of 
(16 to 160 /-LM), a IG-fold increase in cell yield occurs. In nicotinate. As we show here, A. caulinodans seems to 
contrast, mutants unable to use N2 as the N source exhibit a combine both P. putida aerobic and C. barkeri fermentative 
negligible increase in growth with increasing nicotinate sup­ nicptinate catabolism. . 
plementation (7). In an attempt to elucidate the link between 
the ability to break down nicotinate and fix N2, we have MATERIALS AND METHODS 
investigated A. caulinodans nicotinate catabolism in detail. Bacterial strains and mutants. A. caulinodans ORS571 hasNicotinate catabolism has been described in members of been previously described (6). A library of vector insertionthe genera Pseudomonas (3), Bacillus (8), and Clostridium (Vi) random mutants (carrying IS50-mediated pVP2021 plas­(9, 19). Representatives of all three genera first oxidize 
mid-genome cointegrates) (5) was screened for members 
nicotinate to 6-hydroxynicotinate (6-0H-Nic), but While 
unable to use nicotinate as the sole N source (Nic- pheno­Pseudomonas fluorescens and Bacillus subtilis continue to type). Candidates were collected in three separate experi­
oxidize the pyridine ring structure, Clostridium barkeri 
ments. First, nic::Vi 61103, 61007, 61008, and 61009 (Table instead reduces 6-0H-Nic to 1,4,5,6-tetrahydro-6-oxonico­ 1) were isolated by replica plating random Vi mutants ontotinate (THON) prior to ring breakage. both rich medium (5) and defined minimal medium (4)Whereas most hydroxylases with monooxygenase activity 
containing nicotinate as the sole N source. Colonies that incorporate one atom from O2 into the product, all studied grew on rich medium but not nicotinate-supplemented de­
nicotinate hydroxylases oxidize nicotinate and then rehy­ fined medium were picked; a Nic- phenotype was subse­drate the· product using H20 as the hydroxyl-equivalent quently confirmed by growth tests in similar liquid medium. source. In C. barkeri nicotinate fermentation, nicotinate is Approximately five Nic- mutants were isolated among 104 first oxidized by a cytosolic, NAP+-dependent dehydroge­
total Vi mutants. A second protocol was used to isoiate
nase (12). The B. subtilis nicotinate hydroxylase seems to be 
mutant strain 61040 (Table 1). Mutagenized cells were first 
a soluble, iron-containing flavoprotein that catalyzes O2 plated on defined medium containing both L-histidine and
consumption (8, 10, 11). In contrast, P. fluorescens and 
nicotinate as N sources. Because A. caulinodatts grows 
TABLE 1. Phenotypes of A. caulinodans wild type
and nic::Vi mutants
Relevant characteristic
Strains
Nic' 60Hb TMPDc' Nodd Nifr Fixf
ORS571 + + + + + +
61007 + + + + +
61008 + + + + +
61009 + + + +
61020 + + + +
61040 + + +
61103 + + + +
a Utilization of nicotinate as the N source.
b Utilization of 6-OH-Nic as the N source.
TMPD activity as described in Materials and Methods.
d Nodule formation on S. rostrata; +, lack of leghemoglobin in nodules (4).
e Free-living N2 fixation as measured by acetylene reduction; +, less than
50%o of wild-type ethylene formation (4).
f Nodule N2 fixation as measured by acetylene reduction (4); +, less than
50o that of wild type.
poorly on L-histidine as the N source, small colonies were
picked and candidates were retested for growth in defined
liquid medium containing nicotinate as the sole N source.
Nic- mutants were isolated at similar frequencies by the two
protocols. Only mutant 61009 proved unable to grow on
6-OH-Nic as the sole N source. To isolate additional mutants
unable to grow on 6-OH-Nic, the second protocol was
repeated using 6-OH-Nic in lieu of nicotinate. Mutant 61020,
unable to use 6-OH-Nic as the sole N source, was isolated in
this way.
Cell extracts and fractionation procedures. A. caulinodans
wild-type cells, cultured in a defined minimal medium con-
taining nicotinate as the sole N source (4), were harvested in
late exponential phase by centrifugation at 4,000 x g for 15
min. Cells were suspended in a stabilizing buffer (7 mM
sodium potassium phosphate, pH 7.0, 10% glycerol) and
then frozen at -70°C until needed. Enzyme activities from
rescued cells remained constant over several months of
freezing. Thawed cells were lysed by two passes through a
French pressure cell at 2,000 lb/in2. Unbroken cells were
removed by centrifugation at 4,000 x g for 15 min. Cell
extracts were centrifuged for 25 min at 300,000 x g in a
miniultracentrifuge (model TL100.2; Beckman Instruments,
Inc.). On the basis of calculations using the Svedberg
equation, only particles with a sedimentation coefficient
greater than 30S should have been pelleted. The upper, red,
gelatinous pellet layer (envelope fraction) was then sus-
pended in 4 mM NaCl-7 mM sodium potassium diphosphate
buffer; the supernatant was considered the cytosolic frac-
tion.
Identification of cyclic nicotinate catabolic intermediates.
Cell extracts were diluted to 10 mg ml of total protein-1, and
two 300-pu samples were incubated at 37°C. To the experi-
mental sample, nicotinate was added at a final concentration
of 0.1%; to the experimental control, phosphate buffer was
added. The unmetabolized compound theobromine was
added in all cases to gauge percent recovery. Samples (50 pul)
were removed at 0, 15, 30, 60, and 90 min and extracted with
125 p.1 of 95% formic acid-5% butanol solution. Protein
precipitates were collected by centrifugation (30 min at
15,000 x g), and 20-pd supernatant samples were subjected
to high-performance liquid chromatography (HPLC) over a
C18 column (4.6 by 250 mm; Econosil; Alltech Associates,
Inc.) with a mobile phase of 50 mM sodium potassium
phosphate, pH 5.6. Separated compounds were detected by
UV light absorbance at 254 nm.
To purify nicotinate catabolism intermediates, nic: :Vi
mutant strain 61009 was cultured to late exponential growth
phase in defined, minimal medium containing 0.1% 6-OH-
Nic and the filtered growth medium was lyophilized. The
residue was then suspended in 3 ml of sodium potassium
phosphate buffer, passed through a C18 cartridge to remove
excess hydrophobic material, and subjected to preparative
HPLC. A C18 column (10 by 250 mm; Econosil, Alltech) with
a mobile phase of 50 mM ammonium acetate, pH 4.2, was
used to purify substituents. Under these conditions, THON
exhibited a 10-min-longer retention time relative to all other
absorbance peaks. Fractions containing THON were pooled
and lyophilized, and the residue was suspended in 1 ml of
water. This solution was acidified to pH 1.0 with reagent
grade sulfuric acid and then extracted for 24 h with 50 ml of
diethyl ether. Ether phases were evaporated at room tem-
perature under argon, and the resulting white power residue
was dissolved in deuterated dimethyl sulfoxide for measure-
ment of proton magnetic resonance spectra. Nuclear mag-
netic resonance was performed in a 300-MHz General Elec-
tric GN300 machine. A Finnegan mass spectrometer with
either methane or isobutane as the ionizing gas was used for
molecular weight determinations. UV absorbance scans
were performed on a Hitachi 100-80 spectrophotometer.
Atomic composition was assayed with a Perkin-Elmer 240B
element analyzer.
Enzyme assays and chemicals. Strains were tested for
TMPD oxidase activity by rubbing a picked colony on filter
paper saturated with 5% TMPD in water. Blue color in 1 to
2 min indicates a positive response; colony smears remaining
white for 20 to 30 min were considered negative. Acetylene
reduction assays and nodulation studies on the host plant
Sesbania rostrata were performed as previously described
(4). All 02 consumption experiments were performed in a
modified Warburg apparatus at 30°C. Vials contained whole
cells, 7 mM sodium potassium phosphate buffer, and sub-
strate adjusted to a 2.4-ml final volume.
6-OH-Nic has an absorbance peak at 295 nm (e 3.6 x
103) at which nicotinate absorbs negligibly (12, 13). There-
fore, nicotinate hydroxylase activity was assayed by follow-
ing increase in A295 in a Hitachi 100-80 recording spectro-
photometer at room temperature (about 23°C). Both the
sample and reference cuvettes contained cell fractions di-
luted to 1 ml in 7 mM sodium potassium phosphate buffer,
pH 7.0; the sample cuvette contained 1 mM nicotinate.
Cytochrome oxidase inhibitors and electron acceptors were
added to both cuvettes.
Change in A340 was used to detect reduction and oxidation
of both NADPH and NADH. Methylene blue and ferricya-
nide reductions were followed at A609 and A450, respectively.
THON degradation by cell extracts and cell fractions was
determined by decrease in A270 (a peak for THON at pH 7;
e 1.4 x 104) when THON (0.1 mM) was added to the
sample cuvette. Protein was determined by the Bradford
method (2).
Reference materials, including nicotinate (Sigma Chemical
Co.), 6-OH-Nic (Aldrich Chemical Co.), and [18O]H20(Am-
ersham Corp.), all were purchased. Nicotinate analogs,
2-chloronicotinate, 6-chloronicotinate, 2-aminonicotinate,
2,4-dihydroxypyridine, mimosine, and N-methylnicotinate
all were purchased (Sigma). 2,5-Dihydroxypyridine was the
generous gift of E. R. Behrman. Also purchased were the
cytochrome oxidase inhibitors sodium cyanide, sodium
azide (Sigma), and N-phenylimidazole (Trans World Chem-
icals).
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TABLE 2. Comparison between results of two studies
Proton NMR HCI NaOH
THON peaks (ppm)a Xmax (nm) e (104) kmax (nm) e (104) Composition Mol wt
Previously reportedb 2.6,c 7.3d 277 1.40 268 1.40 C6H7NO3 141
This study 2.5,c 7 ld 275 1.45 268 1.4 C6H7NO3 141
a Tsai et al. (18) used DCCI as the solvent, and we used deuterated dimethyl sulfoxide, which may account for the slight difference in peak positions. NMR,
Nuclear magnetic resonance.
b As reported by Tsai et al. (18).
c A multiplet for both; a signal from the protons on C-4 and C-5.
d A doublet for both; a signal from the proton on C-2.
RESULTS
A. caulinodans mutant and wild-type growth properties. Six
A. caulinodans nic::Vi mutants, strains 61007, 61008, 61009,
61020, 61040, and 61103, were isolated and phenotypically
characterized (Table 1). Two mutants, strains 61009 and
61020, were unable to use 6-OH-Nic as the N source but
were unaffected in nicotinate hydroxylase activity, N2 fixa-
tion, and S. rostrata nodulation. Among those mutants able
to utilize 6-Oll-Nic as a N source, strains 61040 and 61103
were also unable to oxidize TMPD and were impaired in
both N2 fixation and nodulation abilities. The nic::Vi mu-
tants 61007 and 61008 had little or no nicotinate hydroxylase
activity and were generally unimpaired in both N2 fixation
and nodulation.
A. caulinodans wild type and all mutants required at least
1 ,uM nicotinate for good growth on any N source, including
6-OH-Nic. When defined medium contained L-glutamine as
the sole N source, wild-type cultures doubled their cell
counts every 3 h; cultures doubled every 11 h with nicotinate
as the sole N source. This finding is consistent with the low
rates of enzyme activity seen in cell extracts (see below).
Because A. caulinodans wild type grew poorly on either
nicotinate or 6-OH-Nic as the C source, experiments at-
tempting to show growth on potential (N-free) ring breakage
products proved ambiguous. As C substrates for A. caulsn-
odans wild-type growth, fumarate, propionate, and glucose
all proved poor, while malate, succinate, pyruvate, and
acetate proved excellent.
A. caulinodans growth on nicotinate as the sole N source
was inhibited by none of the following nicotinate analogs at
concentrations up to 10 mM: 2-chloronicotinate, 6-chloro-
nicotinate, 2-aminonicotinate, 2,4-dihydroxypyridine, 2,5-
dihydroxypyridine, and N-methylnicotinate. Neither could
A. caulinodans use any of these compounds as the sole N
source for growth. An exception to this rule was the unusual
amino acid mimosine, which at 5 mM completely inhibited
growth in defined medium with nicotinate as the sole N
source. Growth on other N sources was not inhibited by
mimosine up to 10 mM.
Purification of nicotinate catabolic intermediates 6-OH-Nic
and THON. To identify compounds produced during nico-
tinate catabolism, A. caulinodans cell extracts were incu-
bated with excess nicotinate; HPLC was then used to
separate and purify small molecules from reaction mixtures
(Materials and Methods). On the standard chromatogram
(Materials and Methods), nicotinate eluted at 4.2 min
whereas the marker compound theobromine eluted at 3.2
min. Aside from theobromine, no peaks appeared in the
control experiment in which no nicotinate was added. When
nicotinate was added to extracts, three UV-absorbing peaks
appeared and increased in area with increasing incubation
time. The absorbance peak eluting at 3.5 min was identified
as 6-OH-Nic both by coelution with a standard and by its UV
absorbance spectrum. Fractions containing the other two
peaks (retention times of 2.8 and 10 min, respectively) were
collected when the A254 was greater than 0.20. The fraction
collected at 2.8 min showed no UV absorbance peaks but
rather a continual increase in UV absorbance versus de-
creasing wavelength; this fraction is therefore unlikely to
contain any cyclic compound. From thin-layer chromatog-
raphy (on silica with a mobile phase of water-EtOH-NH3),
this fraction appeared to comprise at least three different
components. The fraction collected at 10 min showed a UV
absorbance maximum at 273 nm at pH 5 and was assumed to
represent a product of partial nicotinate degradation.
To test completion of nicotinate catabolism, nic::Vi mu-
tants 61103 and 61008 were cultured in the presence of
excess nicotinate. From these cultures, growth media were
subsequently filtered, extracted, and subjected to HPLC. As
determined by these chromatograms, only nicotinate was
present in the exhausted growth media. Mutant strains 61009
and 61020 produced 6-OH-Nic (which eluted at 3.5 min) as
well as compound(s) eluting at 10 min but did not yield any
UV-absorbing compounds eluting at 2.8 min.
When the mutant strain 61009 was cultured in defined
medium supplemented with excess 6-OH-Nic, large amounts
of the compound(s) eluted at 10 min (see above) were
obtained after preparative HPLC (Materials and Methods).
The proton NMR spectrum of the principal, purified com-
pound closely resembled that reported for THON produced
during C. barkeri nicotinate fermentation (9, 19). The UV
absorbance spectrum for this compound had an absorbance
peak at 275 nm in acidic solution that shifted to 268 nm in
basic solution and was identical to that of THON. From
mass spectrometry, a molecular weight of 141 was obtained
for this compound; elemental analysis was consistent with a
molecular formula of C6H7NO3 (Table 2).
As isolated from mutant 61009, THON would not serve as
the sole N source for A. caulinodans. However, THON
degradation was detected in A. caulinodans cell extracts and
occurred at rates on the same order of magnitude as rates of
nicotinate hydroxylation (discussed below). Neither strain
61009 nor the wild type cultured with ammonium as the N
source showed significant THON breakdown activity (see
Table 4).
02 consumption during A. caudinodans nicotinate catabo-
lism. Using a modified Warburg apparatus (Materials and
Methods), 02 consumption was measured in A. caulinodans
wild-type cells previously grown in defined medium with
nicotinate as the sole N source. While complete combustion
of 1 mol of nicotinate would require 5.5 mol of 02, only 3.5
mol of °2 was consumed in this experiment (Fig. 1). In a
parallel control experiment, only 2.5 mol of °2 was con-
sumed per mol of succinate; in both cases, some substrate
may have been used in anabolic reactions.
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FIG. 1. 02 consumption by A. caulinodans wild type. Cells were
grown in defined medium with nicotinate as the sole N source,
harvested by centrifugation, washed, and resedimented. Cells were
suspended in phosphate buffer, and approximately 109 cells were
added to each Warburg vial. Plots using nicotinate (L) or succinate
(U) as the substrate had the 02 consumption of a control with no
substrate subtracted from them. Substrate (2 ,umol) was added in all
cases; each plot is an average of two parallel experiments.
When strain 61009 was similarly tested, 0.5 mol of 02 per
mol of nicotinate was consumed; no 02 was consumed at the
expense of 6-OH-Nic (Fig. 2). Because more 02 was con-
sumed per mol of nicotinate than per mol of succinate and
because the conversion of nicotinate to THON required only
a single two-electron oxidation, some ring breakage products
must be further oxidized by A. caulinodans (see Discussion).
Nicotinate hydroxylase incorporates [180]H20 into 6-OH-
NiC. After overnight incubation with 1% nicotinate in a 20%
[18O]H20 solution, mutant 61009 cultures yielded 6-OH-Nic
with a 20% increase in signal at mlz 142, as compared with
the 6-OH-Nic isolated from a light water-nicotinate solution
(Fig. 3). Using isobutane as the ionizing gas shifts all
molecular weight readings to M+1; thus, 6-OH-Nic gave a
maximum at mlz 140 instead of 139. No solvent exchange
of 6-OH-Nic hydroxyl groups was detected. When purified,
20% ['80]6-OH-Nic was incubated in light-water solution for
2 days; the proportion of heavy 6-OH-Nic remained 20%.
Localization of nicotinate-induced A. caulinodans nicotinate
hydroxylase activity to the cell envelope. As measured by the
production of 6-OH-Nic (Materials and Methods), nicotinate
hydroxylase activity was found to be concentrated in the cell
envelope fraction of cell extracts. A small amount of nicoti-
nate hydroxylase activity was also evident in the wild-type
cell extract cytosolic fraction (Table 3) which may have been
contaminated with bits of cell envelope. The NADH oxida-
tion rate by the envelope fraction was 10-fold that of
nicotinate oxidation (data not shown). With cells grown on
other N sources, nicotinate hydroxylation rates decreased
dramatically (Table 4). Moreover, rates of THON break-
down, measured by the disappearance of THON (Materials
and Methods), also decreased. Unlike nicotinate hydroxy-
Time (hrs)
FIG. 2. 02 consumption by nic::Vi mutant 61009. Cells were
grown in minimal medium supplemented with both L-glutamate as
the N source and 0.1% nicotinate. Cells were washed and harvested
as in Fig. 1 with similar amounts of cells added to each vial. Plots
were obtained from vials containing 2 ,umol of nicotinate (O) or
6-OH-Nic (L) as the substrate, having had values for substrate-free
controls subtracted. Each plot is an average of three parallel
experiments.
lase, THON breakdown activity was not membrane associ-
ated (data not shown).
A. caulinodans particulate nicotinate hydroxylase activity is
coupled to 02 reduction. In descending order of potency,
nicotinate hydroxylase activity in particulate fractions was
inhibited by the cytochrome oxidase inhibitors cyanide,
N-phenylimidazole, and azide. Except for a notable differ-
ence in azide sensitivity, NADH dehydrogenase activity was
similarly affected by these inhibitors (Table 5). After poison-
ing with cyanide, nicotinate hydroxylase activity could not
be restored by adding NAD+, NADP+, or methylene blue.
However, when ferricyanide was added to accept electrons
in lieu of 02, activity was restored. In contrast to ferricya-
nide reduction in the presence of 1 mM nicotinate, no
reduction of NAD+, NADP+, or methylene blue could be
detected by standard spectrophotometric techniques.
DISCUSSION
When catabolizing nicotinate, A. caulinodans and all other
similarly investigated bacteria produce, as an initial interme-
diate, 6-OH-Nic using H20 as the hydroxyl-equivalent
source (3, 8, 9; this study). Whereas other aerobic organisms
next oxidize 6-OH-Nic to yield 2,6-dihydroxynicotinate or
2,5-dihydroxypyridine (3, 8), A. caulinodans instead reduces
6-OH-Nic to THON (this study). Because THON break-
down and its regulation coordinated with nicotinate hydrox-
ylase activities in both the nic: :Vi mutant and wild-type
analyses above, THON is a true A. caulinodans nicotinate
catabolic intermediate. An analogous reduction of 6-OH-Nic
to THON has been reported for C. barkeri during anaerobic
fermentations (9, 19).
Surprisingly, A. caulinodans seems to share its nicotinate
catabolic properties with the obligate anaerobic Clostridium
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FIG. 3. Cells of the nic::Vi mutant 61009 were grown overnight
with glutamate as the N source, induced for nicotinate catabolic
enzymes by the addition of excess nicotinate for 4 h, and harvested
by centrifugation. Cells (2 g) were then incubated for 24 h in a 5-ml
solution of 1% nicotinate, with or without ['80]H20. Cells were
removed by centrifugation and filtration. The 6-OH-Nic in the
filtrate was isolated by preparative HPLC and mass spectra were
taken. (A) Mass spectrum of 6-OH-Nic after incubation with
[160]H20. (B) Mass spectrum of 6-OH-Nic after incubation with[180]H20-
spp. and not with the more closely related aerobes. But
because infected plant tissue constitutes a microaerobic
environment that is eventually 02 buffered at submicromolar
02 concentrations by leghemoglobin (1), A. caulinodans
redox-balanced nicotinate catabolism might allow complete
nicotinate degradation to tricarboxylic acid cycle intermedi-
ates which can be efficiently stored as poly-3-hydroxybu-
tyrate (20).
Although nicotinate metabolites after ring breakage were
not characterized, some ring breakage products must be
further oxidized to account for the amount of 02 consumed
per mol of nicotinate. Since mutant 61009 did not catabolize
this pyridine ring, only 0.5 mol of the 3.5 mol of 02
consumed per mol of nicotinate can be attributed to reac-
tions occurring before ring breakage (see Results). If A.
TABLE 3. 6-OH-Nic production of A. caulinodans cells grown
on nicotinate as the sole N source
Fraction Protein Total activity Sp actFraction (mg ml-) (mmol min-') (mmol min- mg
of protein-')
Cell lysate 42 44 1.4
Cell envelope 11 28 4.4
Cytosol 30 10 0.4
TABLE 4. Nicotinate hydroxylase and THON breakdown
activities in cell extracts prepared from cultures
grown with several N sources
Nicotinate hydroxylase THON breakdown
N source (mmol min-' mg (mmol min-' mg
of protein-') of protein')
N2 0.36 0.9
NH4+ 0.03 0.01
L-Glutamate 0.14 0.2
Nicotinate 1.4 0.45
caulinodans continues to mimic Clostridium spp. nicotinate
catabolism, ring breakage would produce ammonium and
2-methyleneglutarate, which would be converted stoichio-
metrically into equal amounts of pyruvate and propionate
(19). By analogy to odd-chain fatty acid oxidation, propio-
nate might be carboxylated to eventually produce succinate
(Fig. 4).
In Clostridium spp., nicotinate hydroxylation is conducted
by a soluble, NAD+-dependent dehydrogenase (12). How-
ever, A. caulinodans nicotinate hydroxylase activity was
membrane associated and seemed to require 02, not NAD+,
as the terminal electron acceptor. Nicotinate hydroxylase
and NADH dehydrogenase activities were inhibited by azide
to strikingly different degrees (Table 5). In addition, neither
mutant 61103 nor 61040 could oxidize TMPD (Table 1).
Analogously, hydroxylation of nicotinate in P. putida and P.
fluorescens is membrane bound and coincides with TMPD
oxidation (13, 14, 15). Both substrates reduce an electron
transport chain other than that involving NADH dehydroge-
nase, as evidenced by cytochrome spectra and inhibitor
studies with azide in P. putida (15). Thus, A. caulinodans
may have a nicotinate electron transport system similar to
these pseudomonads.
A. caulinodans nicotinate catabolism seems to have bor-
rowed from both aerobic and anaerobic pathways. However,
this revelation sheds little light on how degradation of this
essential vitamin enhances N2 fixation. From this study,
neither nicotinate nor 6-OH-Nic catabolism seems essential
for N2 fixation. Under N2-fixing conditions, increased nico-
tinate levels might produce increased growth yields simply
because competitive nicotinate catabolism depletes cells of
the vitamin. Regardless, mutants 61103 and 61040 are im-
paired in both free-living and symbiotic N2 fixation (Table 1).
Intriguingly, Bradyrhizobium japonicum and Rhizobium
phaseoli mutants isolated by their inability to oxidize TMPD
are either unable to nodulate their host plants or produce
ineffective (Fix-) nodules (17, 18). Since the A. caulinodans
Nic- mutants 61103 and 61040 were also unable to oxidize
TABLE 5. Effects of inhibitors on both nicotinate hydroxylase
and NADH dehydrogenase activities measured
in crude cell envelope fractions
Nicotinate NADH
Inhibitor C(MnMc)n hydroxylase dehydrogenaseinhibition (%) inhibition (%)
CN- 2.5 79 93
5.0 86 95
N-Phenylimidazole 2.5 30 42
5.0 52 64
N3- 2.5 6 36
5.0 16 57
10 45 73
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FIG. 4. Proposed pathway for A. caulinodans nicotinate catab-
olism. Reactions subsequent to ring breakage, including the involve-
ment of vitamin B12 and the ferredoxin cycle, are those of Clostrid-
ium spp. The conversion of propionate to succinyl-coenzyme A
(CoA) follows the path of odd-chain fatty acid degradation.
TMPD, the electron transport chain necessary for nicotinate
hydroxylation and TMPD oxidation must contribute in some
way to an intracellular environment conducive to high levels
of N2 fixation.
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